Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
about
Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@en
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@nl
type
label
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@en
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@nl
prefLabel
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@en
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@nl
P2093
P2860
P1476
Anti-CENP-B and anti-TOPO-1-co ...... via classical p53-p21 pathway.
@en
P2093
Chia-Li Yu
Pei-Hsuan Lai
Song-Chou Hsieh
P2860
P356
10.1007/S10067-017-3845-9
P577
2017-09-23T00:00:00Z